Effects of herbal extracts and compounds and pharmacological agents on pulmonary fibrosis in animal models: a review

Kikuchi, 2010, Nrf2 protects against pulmonary fibrosis by regulating the lung oxidant level and Th1/Th2 balance, Respir Res, 11, 31, 10.1186/1465-9921-11-31 Naghani, 2016, Protective effects of hydroalcoholic extract of Hypericum perforatum against bleomycin-induced pulmonary fibrosis in rats, J Babol Univ Med Sci, 18, 44 Nalysnyk, 2012, Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature, Eur Respir Rev, 21, 355, 10.1183/09059180.00002512 Raghu, 2014, Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001–11, Lancet Respir Med, 2, 566, 10.1016/S2213-2600(14)70101-8 Lynch, 2016, Idiopathic pulmonary fibrosis: epidemiology, clinical features, prognosis, and management, Semin Respir Crit Care Med, 37, 331, 10.1055/s-0036-1582011 Javadi, 2015, Protective effects of celery (Apium graveloens) seed extract on bleomycin-induced pulmonary fibrosis in rats, J Babol Univ Med Sci, 17, 70 Bahrami-Karkevandi, 2011, The effects of hydroalcoholic extract of Artemisia Aucheri on bleomycin induced pulmonary fibrosis in rats, J Shahrekord Univ Med Sci, 12, 33 Gross, 2001, Idiopathic pulmonary fibrosis, N Engl J Med, 345, 517, 10.1056/NEJMra003200 Tang, 2011, Effect of tranilast on bleomycin-induced pulmonary fibrosis in a rat model, Afr J Pharm Pharmacol, 5, 1315, 10.5897/AJPP11.448 Ertekin, 2007, Investigation of the effects of alpha-tocopherol on the levels of Fe, Cu, Zn, Mn, and carbonic anhydrase in rats with bleomycin-induced pulmonary fibrosis, Biol Trace Elem Res, 116, 289, 10.1007/BF02698013 Kakugawa, 2010, Localization of HSP47 mRNA in murine bleomycin-induced pulmonary fibrosis, Virchows Arch, 456, 309, 10.1007/s00428-009-0876-x American Thoracic Society, 2002, American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias, Am J Respir Crit Care Med, 165, 277, 10.1164/ajrccm.165.2.ats01 Hemmati, 2013, Preventive effects of pomegranate seed extract on bleomycin-induced pulmonary fibrosis in rat, Jundishapur J Nat Pharm Prod, 8, 76, 10.17795/jjnpp-8821 Selman, 2001, Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy, Ann Intern Med, 134, 136, 10.7326/0003-4819-134-2-200101160-00015 Katzenstein, 1998, Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification, Am J Respir Crit Care Med, 157, 1301, 10.1164/ajrccm.157.4.9707039 Kuhn, 1989, An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis, Am Rev Respir Dis, 140, 1693, 10.1164/ajrccm/140.6.1693 Kuhn, 1991, The roles of the myofibroblast in idiopathic pulmonary fibrosis. Ultrastructural and immunohistochemical features of sites of active extracellular matrix synthesis, Am J Pathol, 138, 1257 Hemmati, 1999, Increased myofibroblast contractile sensitivity in paraquat pretreated rat lung tissue, Life Sci, 65, 2325, 10.1016/S0024-3205(99)00499-3 Moeller, 2008, The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?, Int J Biochem Cell Biol, 40, 362, 10.1016/j.biocel.2007.08.011 Martin, 2006, The transforming growth factor-beta (TGF-β) family and pulmonary fibrosis, Drug Discov Today Dis Mech, 3, 99, 10.1016/j.ddmec.2006.03.006 Safaeian, 2009, The effects of Silymarin in bleomycin-induced pulmonary fibrosis in mice, Qom Univ Med Sci J, 3, 381 Dinis-Oliveira, 2008, Paraquat poisonings: mechanisms of lung toxicity, clinical features, and treatment, Crit Rev Toxicol, 38, 13, 10.1080/10408440701669959 Hemmati, 2002, The role of sodium cromolyn in treatment of paraquat-induced pulmonary fibrosis in rat, Pharmacol Res, 46, 229, 10.1016/S1043-6618(02)00122-6 Mojiri-Forushani, 2017, Protective effect of valsartan on beleomycin-induced fibrosis, Jundishapur J Nat Pharm Prod, 12, e33973 Richeldi, 2014, Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis, N Engl J Med, 370, 2071, 10.1056/NEJMoa1402584 Jiang, 2012, Adverse events of pirfenidone for the treatment of pulmonary fibrosis: a meta-analysis of randomized controlled trials, PLoS One, 7, e47024, 10.1371/journal.pone.0047024 Javad-Mousavi, 2016, Protective effect of Berberis vulgaris fruit extract against paraquat-induced pulmonary fibrosis in rats, Biomed Pharmacother, 81, 329, 10.1016/j.biopha.2016.04.027 Chilakapati, 2014, Passion fruit peel extract attenuates bleomycin-induced pulmonary fibrosis in mice, Can J Physiol Pharmacol, 92, 631, 10.1139/cjpp-2014-0006 Li L, Li D, Xu L, Zhao P, Deng Z, Mo X, Li P, Qi L, Li J, Gao J. Total extract of Yupingfeng attenuates bleomycin-induced pulmonary fibrosis in rats. Phytomedicine. 22(1): 111–119. Ghorashi, 2017, The attenuating effect of aqueous extract of licorice on bleomycin-induced pulmonary fibrosis in mice, Food Agric Immunol, 28, 67, 10.1080/09540105.2016.1203294 Hemmati, 2011, Yarrow (Achillea millefolium L.) extract impairs the fibrogenic effect of bleomycin in rat lung, J Med Plant Res, 5, 1843 Hemmati, 2006, Protective effect of grape seed extract against the fibrogenic effect of bleomycin in rat lung, Iran J Pharm Sci, 2, 143 Hemmati, 2008, A comparative study of grape seed extract and vitamin E effects on silica-induced pulmonary fibrosis in rats, Pulm Pharmacol Ther, 21, 668, 10.1016/j.pupt.2008.04.004 Asghari, 2015, Hydro-alcoholic extract of Raphanus sativus L. var niger attenuates bleomycin-induced pulmonary fibrosis via decreasing transforming growth factor-β1 level, Res Pharm Sci, 10, 429 Kar, 2015, Therapeutic use of fisetin, curcumin, and mesoporous carbaon nanoparticle loaded fisetin in bleomycin-induced idiopathic pulmonary fibrosis, Biomed Res Ther, 2, 250 Kandhare, 2015, Effect of glycosides-based standardized fenugreek seed extract in bleomycin-induced pulmonary fibrosis in rats: decisive role of Bax, Nrf2, NF-κB, Muc5ac, TNF-α and IL-1β, Chem Biol Interact, 237, 151, 10.1016/j.cbi.2015.06.019 Zhan, 2016, Protective effect of ginsenoside Rg1 on bleomycin-induced pulmonary fibrosis in rats: involvement of caveolin-1 and TGF-β1 signal pathway, Biol Pharm Bull, 39, 1284, 10.1248/bpb.b16-00046 Malayeri, 2016, A comparison of the effects of quercetin hydrate with those of vitamin E on the levels of IL-13, PDGF, TNF-α, and INF-γ in bleomycin-induced pulmonary fibrosis in rats, Jundishapur J Nat Pharm Prod, 11, e27705, 10.17795/jjnpp-27705 Verma, 2013, Evaluating the ameliorative potential of quercetin against the bleomycin-induced pulmonary fibrosis in Wistar rats, Pulm Med, 2013, 10.1155/2013/921724 Chitra, 2013, Berberine attenuates bleomycin-induced pulmonary toxicity and fibrosis via suppressing NF-κB dependant TGF-β activation: a biphasic experimental study, Toxicol Lett, 219, 178, 10.1016/j.toxlet.2013.03.009 Nikbakht, 2015, Protective effect of gallic acid against bleomycin-induced pulmonary fibrosis in rats, Pharmacol Rep, 67, 1061, 10.1016/j.pharep.2015.03.012 You, 2014, The green tea extract epigallocatechin-3-gallate inhibits irradiation-induced pulmonary fibrosis in adult rats, Int J Mol Med, 34, 92, 10.3892/ijmm.2014.1745 Larki-Harchegani, 2013, Evaluation of the effects of caffeic acid phenethyl ester on prostaglandin E2 and two key cytokines involved in bleomycin-induced pulmonary fibrosis, Iran J Basic Med Sci, 16, 850 Larki, 2013, Regulatory effect of caffeic acid phenethyl ester on type I collagen and interferon-gamma in bleomycin-induced pulmonary fibrosis in rat, Res Pharm Sci, 8, 243 Zaeemzadeh, 2011, Protective effect of caffeic acid phenethyl ester (CAPE) on amiodarone-induced pulmonary fibrosisin rat, Iran J Pharm Res, 10, 321 Hemmati, 2009, Impact of cafeic acid phenethyl ester (CAPE) on amiodarone-induced pulmonary fibrosis in rat, Toxicol Lett, 189, S168, 10.1016/j.toxlet.2009.06.693 Akgedik, 2012, Effect of resveratrol on treatment of bleomycin-induced pulmonary fibrosis in rats, Inflammation, 35, 1732, 10.1007/s10753-012-9491-0 Hemmati, 2015, Sildenafil, a selective inhibitor of type 5 phosphodiesterase, attenuates bleomycin-induced lung fibrosis in rat, Biological Forum, 7, 1067 Khodayar, 2014, The preventive effect of atorvastatin on paraquat-induced pulmonary fibrosis in the rats, Adv Pharm Bull, 4, 345 Mikaili, 2012, The protective effect of penicillamine against bleomycine-induced pulmonary fibrosis in rats, Adv Environ Biol, 204 Mikaili, 2011, Evaluation of the effects of nicotinamide on the bleomycin-induced pulmonary fibrosis in rat, Int J Anim Vet Adv, 3, 330 Ermis, 2013, Protective effect of dexpanthenol on bleomycin-induced pulmonary fibrosis in rats, Naunyn-Schmiedeberg's Arch Pharmacol, 386, 1103, 10.1007/s00210-013-0908-6 Kalayarasan, 2013, Diallylsulfide attenuates excessive collagen production and apoptosis in a rat model of bleomycin induced pulmonary fibrosis through the involvement of protease activated receptor-2, Toxicol Appl Pharmacol, 271, 184, 10.1016/j.taap.2013.04.021 Hemmati, 2008, The protective effect of cetirizine against bleomycin-induced pulmonary fibrosis in rats, Pak J Med Sci, 24, 813 Hemmati, 2008, Protective effect of ketotifen on bleomycin-induced pulmonary fibrosis in rat, J Pharm Chem, 2, 65 Guo, 2015, Losartan attenuates paraquat-induced pulmonary fibrosis in rats, Hum Exp Toxicol, 34, 497, 10.1177/0960327114543840 Wang, 2000, Abrogation of bleomycin-induced epithelial apoptosis and lung fibrosis by captopril or by a caspase inhibitor, Am J Physiol Lung Cell Mol Physiol, 279, L143, 10.1152/ajplung.2000.279.1.L143 Ghazi-Khansari, 2007, Antifibrotic effect of captopril and enalapril on paraquat-induced lung fibrosis in rats, J Appl Toxicol, 27, 342, 10.1002/jat.1212 Otsuka, 2004, Reduction of bleomycin-induced lung fibrosis by candesartan cilexetil, an angiotensin II type 1 receptor antagonist, Thorax, 59, 31, 10.1136/thx.2003.000893 Marut, 2013, Amelioration of systemic fibrosis in mice by angiotensin II receptor blockade, Arthritis Rheum, 65, 1367, 10.1002/art.37873 Amirshahrokhi, 2013, Anti-inflammatory effect of thalidomide in paraquat-induced pulmonary injury in mice, Int Immunopharmacol, 17, 210, 10.1016/j.intimp.2013.06.005 Liu, 2016, Salvianolic acid B protects against paraquat-induced pulmonary injury by mediating Nrf2/Nox4 redox balance and TGF-β1/Smad3 signaling, Toxicol Appl Pharmacol, 309, 111, 10.1016/j.taap.2016.08.004 Aoki, 2009, Pioglitazone, a peroxisome proliferator-activated receptor γ ligand, suppresses bleomycin-induced acute lung injury and fibrosis, Respiration, 77, 311, 10.1159/000168676